Ventricular remodeling in ischemic cardiomyopathy

Stem Cell Therapy and Tissue Engineering for Cardiovascular Repair: From Basic Research to Clinical Applications

Volumn , Issue , 2006, Pages 3-22

  Klotz, Stefan ^a,b   Burkhoff, Daniel ^a  

^a Department of Medicine   (United States)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885478794     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-30939-X_1     Document Type: Chapter

References (61)

1. Anversa P, Kajstura J, Olivetti G. Myocyte death in heart failure. Curr Opin Cardiol. May 1996;11(3):245-251.
2. Mann DL. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res. Nov. 29 2002;91(11):988-998.
3. Mann DL. Stress-activated cytokines and the heart: from adaptation to maladaptation. Annu Rev Physiol. 2003;65:81-101.
4. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. Apr. 1990;81(4):1161-1172.
5. Todaka K, Zhu S, Gu A, et al. Changes in left ventricular mechanics and energetics in canine microembolization model of heart failure. Journal of the American College of Cardiology. 1995;25:133A.
6. He KL, Dickstein M, Sabbah HN, et al. Mechanisms of heart failure with well preserved ejection fraction in dogs following limited coronary microembolization. Cardiovasc Res. Oct. 1 2004;64(1):72-83.
7. Heerdt PM, Holmes JW, Cai B, et al. Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation. Nov. 28 2000;102(22):2713-2719.
8. Madigan JD, Barbone A, Choudhri AF, et al. Time course of reverse remodeling of the left ventricle during support with a left ventricular assist device. J Thorac Cardiovasc Surg. May 2001;121(5):902-908.
9. Mirsky I, Pasipoularides A. Clinical assessment of diastolic function. Prog Cardiovasc Dis. Jan-Feb. 1990;32(4):291-318.
10. Anversa P, Beghi C, Kikkawa Y, et al. Myocardial response to infarction in the rat. Morphometric measurement of infarct size and myocyte cellular hypertrophy. Am J Pathol. Mar. 1985;118(3):484-492.
11. McCarthy PM, Savage RM, Fraser CD, et al. Hemodynamic and physiologic changes during support with an implantable left ventricular assist device. J Thorac Cardiovasc Surg. Mar. 1995;109(3):409-417; discussion 417-408.
12. Levin HR, Oz MC, Chen JM, et al. Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation. Jun. 1 1995;91(11):2717-2720.
13. Barbone A, Holmes JW, Heerdt PM, et al. Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: a primary role of mechanical unloading underlying reverse remodeling. Circulation. Aug. 7 2001;104(6):670-675.
14. Terracciano CM, Hardy J, Birks EJ, et al. Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy. Circulation. May 18 2004;109(19) 2263-2265.
15. Zafeiridis A, Jeevanandam V, Houser SR, et al. Regression of cellular hypertrophy after left ventricular assist device support. Circulation. Aug. 18 1998;98(7):656-662.
16. Klotz S, Naka Y, Oz M, et al. Biventricular Assist Device-Induced Right Ventricular Reverse Structural and Functional Remodeling. J Heart Lung Transplant. 2004; in press.
17. Calaghan SC, White E. The role of calcium in the response of cardiac muscle to stretch. Prog Biophys Mol Biol. 1999;71(1):59-90.
18. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev. Jan 1999;79(1) 215-262.
19. Houser SR, Piacentino V, 3rd, Weisser J. Abnormalities of calcium cycling in the hypertrophied and failing heart. J Mol Cell Cardiol. Sep. 2000;32(9):1595-1607.
20. Arai M, Alpert NR, MacLennan DH, et al. Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res. Feb. 1993;72(2):463-469.
21. Linck B, Boknik P, Eschenhagen T, et al. Messenger RNA expression and immunological quantification of phospholamban and SR-Ca (2+)-ATPase in failing and nonfailing human hearts. Cardiovasc Res. Apr. 1996;31(4):625-632.
22. Go LO, Moschella MC, Watras J, et al. Differential regulation of two types of intracellular calcium release channels during end-stage heart failure. J Clin Invest. Feb. 1995;95(2):888-894.
23. Hasenfuss G, Reinecke H, Studer R, et al. Relation between myocardial function and expression of sarcoplasmic reticulum Ca (2+)-ATPase in failing and nonfailing human myocardium. Circ Res. Sep. 1994;75(3):434-442.
24. Reiken S, Gaburjakova M, Guatimosim S, et al. Protein kinase A phosphorylation of the cardiac calcium release channel (ryanodine receptor) in normal and failing hearts. Role of phosphatases and response to isoproterenol. J Biol Chem. Jan 3 2003;278(1):444-453.
25. Marx SO, Reiken S, Hisamatsu Y, et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell. May 12 2000;101(4):365-376.
26. Hasenfuss G, Schillinger W, Lehnart SE, et al. Relationship between Na+- Ca2+-exchanger protein levels and diastolic function of failing human myocardium. Circulation. Feb. 9 1999;99(5):641-648.
27. Studer R, Reinecke H, Bilger J, et al. Gene expression of the cardiac Na (+)-Ca2+ exchanger in end-stage human heart failure. Circ Res. Sep. 1994;75(3):443-453.
28. Flesch M, Schwinger RH, Schiffer F, et al. Evidence for functional relevance of an enhanced expression of the Na (+)-Ca2+ exchanger in failing human myocardium. Circulation. Sep. 1 1996;94(5):992-1002.
29. Yoshiyama M, Takeuchi K, Hanatani A, et al. Differences in expression of sarcoplasmic reticulum Ca2+-ATPase and Na+-Ca2+ exchanger genes between adjacent and remote noninfarcted myocardium after myocardial infarction. J Mol Cell Cardiol. Jan 1997;29(1):255-264.
30. Yao A, Su Z, Nonaka A, et al. Abnormal myocyte Ca2+ homeostasis in rabbits with pacing-induced heart failure. Am J Physiol. Oct. 1998;275(4 Pt 2):H1441-1448.
31. Dixon IM, Hata T, Dhalla NS. Sarcolemmal calcium transport in congestive heart failure due to myocardial infarction in rats. Am J Physiol. May 1992;262(5 Pt 2):H1387-1394.
32. Lowes BD, Gilbert EM, Abraham WT, et al. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. N Engl J Med. May 2 2002;346(18):1357-1365.
33. Heerdt PM, Burkhoff D. Reverse Molecular Remodeling of the Failing Human Heart Following Support with a Left Ventricular Assist Device. In: Dhalla NS, editor. Signal Transduction and Cardiac Hypertrophy. Boston: Kluwer Academic Publishers. 2002:19-35.
34. Ogletree-Hughes ML, Stull LB, Sweet WE, et al. Mechanical unloading restores beta-adrenergic responsiveness and reverses receptor downregulation in the failing human heart. Circulation. Aug. 21 2001;104(8):881-886.
35. Morawietz H, Szibor M, Goettsch W, et al. Deloading of the left ventricle by ventricular assist device normalizes increased expression of endothelin ET (A) receptors but not endothelin-converting enzyme-1 in patients with end-stage heart failure. Circulation. Nov. 7 2000;102(19 Suppl 3):111188-193.
36. Bartling B, Milting H, Schumann H, et al. Myocardial gene expression of regulators of myocyte apoptosis and myocyte calcium homeostasis during hemodynamic unloading by ventricular assist devices in patients with end-stage heart failure. Circulation. Nov. 9 1999;100(19 Suppl):11216-223.
37. Grabellus F, Levkau B, Sokoll A, et al. Reversible activation of nuclear factorkappaB in human end-stage heart failure after left ventricular mechanical support. Cardiovasc Res. Jan 2002;53(1):124-130.
38. Heerdt PM, Schlame M, Jehle R, et al. Disease-specific remodeling of cardiac mitochondria after a left ventricular assist device. Ann Thorac Surg. Apr. 2002;73(4):1216-1221.
39. Li YY, Feng Y, McTiernan CF, et al. Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices. Circulation. Sep. 4 2001;104(10):1147-1152.
40. Razeghi P, Mukhopadhyay M, Myers TJ, et al. Myocardial tumor necrosis factoralpha expression does not correlate with clinical indices of heart failure in patients on left ventricular assist device support. Ann Thorac Surg. Dec. 2001;72(6):2044-2050.
41. Aquila-Pastir LA, McCarthy PM, Smedira NG, et al. Mechanical unloading decreases the expression of beta-tubulin in the failing human heart. J Heart Lung Transplant. Feb. 2001;20(2):211.
42. Baba HA, Stypmann J, Grabellus F, et al. Dynamic regulation of MEK/Erks and Akt/GSK-3beta in human end-stage heart failure after left ventricular mechanical support: myocardial mechanotransduction-sensitivity as a possible molecular mechanism. Cardiovasc Res. Aug. 1 2003;59(2):390-399.
43. Frank K, Bolck B, Bavendiek U, et al. Frequency dependent force generation correlates with sarcoplasmic calcium ATPase activity in human myocardium. Basic Res Cardiol. Oct. 1998;93(5):405-411.
44. Holubarsch C, Ruf T, Goldstein DJ, et al. Existence of the Frank-Starling mechanism in the failing human heart. Investigations on the organ, tissue, and sarcomere levels. Circulation. Aug. 15 1996;94(4):683-689.
45. Mulieri LA, Hasenfuss G, Leavitt B, et al. Altered myocardial force-frequency relation in human heart failure. Circulation. May 1992;85(5):1743-1750.
46. Dipla K, Mattiello JA, Jeevanandam V, et al. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation. Jun. 16 1998;97(23):2316-2322.
47. Weber KT. Cardioreparation in hypertensive heart disease. Hypertension. Sep. 2001;38(3 Pt 2):588-591.
48. Reiken S, Wehrens XH, Vest JA, et al. Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure. Circulation. May 20 2003;107(19):2459-2466.
49. Doughty RN, Whalley GA, Walsh HA, et al. Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy Circulation. Jan 20 2004;109(2):201-206.
50. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med. Aug. 1 1991;325(5):293-302.
51. Yue TL, Ma XL, Wang X, et al. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol. Circ Res. Feb. 9 1998;82(2):166-174.
52. Wei S, Chow LT, Sanderson JE. Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction. J Am Coll Cardiol. Jul. 2000;36(1):276-281.
53. Sabbah HN, Sharov VG, Chaudhry PA, et al. Chronic therapy with the acorn cardiac support device in dogs with chronic heart failure: three and six months hemodynamic, histologic and ultrastructural findings. J Heart Lung Transplant. Feb. 2001;20(2):189.
54. St John Sutton MG, Plappert T, Abraham WT, et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation. Apr. 22 2003;107(15):1985-1990.
55. Foray A, Williams D, Reemtsma K, et al. Assessment of submaximal exercise capacity in patients with left ventricular assist devices. Circulation. Nov. 1 1996;94(9 Suppl):11222-226.
56. Mancini DM, Beniaminovitz A, Levin H, et al. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation. Dec. 1 1998;98(22):2383-2389.
57. Levin HR, Oz MC, Catanese KA, et al. Transient normalization of systolic and diastolic function after support with a left ventricular assist device in a patient with dilated cardiomyopathy. J Heart Lung Transplant. Aug. 1996;15(8):840-842.
58. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. Nov. 15 2001;345(20):1435-1443.
59. Lee MS, Makkar RR. Stem-cell transplantation in myocardial infarction: a status report. Ann Intern Med. May 4 2004;140(9):729-737.
60. Klotz S, Dickstein M, Morgan J, et al. Extracellular Matrix Remodeling during Left Ventricular Assist Device Support: Relation between Collagen and Passive Pressure-Volume Relations (Abstract). JACC. 2004; March; 43(5):A225.
61. Klotz S, Foronjy R, Dickstein M, et al. Low Incidence or Myocardial Recovery in LVAD Patients due to Increased Collagen Cross-linking and Myocardial Stiffness (Abstract). Circulation. 2004; Oct. 26 (Suppl).